Zobrazeno 1 - 10 of 40 pro vyhledávání: '"Lisa C. Willcocks"'
1
Akademický článek
A randomised, two-arm (1:1 ratio), double blind, placebo controlled phase III trial to assess the efficacy, safety, cost and cost-effectiveness of Rituximab in treating de novo or relapsing NS in patients with MCD/FSGS (TURING)
Autor: Lisa C Willcocks, Wendi Qian, Ruzaika Cader, Katrina Gatley, Hira Siddiqui, Endurance Tabebisong, Karlena Champion, Andreas Kronbichler, Liz Lightstone, David Jayne, Edward Wilson, Megan Griffith
Publikováno v: BMC Nephrology, Vol 25, Iss 1, Pp 1-11 (2024)
Abstract Background Minimal Change Disease (MCD) and Focal Segmental Glomerulosclerosis (FSGS) are a spectrum of disease causing the nephrotic syndrome (NS), characterised by proteinuria with debilitating oedema, as well as a high risk of venous thro
Externí odkaz: https://doaj.org/article/4c715b51f65b4649acbb9506d2e0f184
Zobrazit plný text záznamu
8
P0373MEPOLIZUMAB THERAPY FOR EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS (EGPA) - ONE YEAR FOLLOW-UP STUDY USING ANTI-IL5 AS A STEROID SPARING THERAPEUTIC APPROACH
Autor: Caroline Owen, Robin Gore, Marcos MartinezDel-Pero, Stella Burns, Lisa C. Willcocks, Pasupathy Sivasothy, Rona M Smith, Allyson Egan, David Jayne, Rachel B Jones
Publikováno v: Nephrology Dialysis Transplantation. 35
Background and Aims EGPA is a small vessel vasculitis characterised by the presence of tissue eosinophilia, necrotising vasculitis and granulomatous inflammation1. Typically, a prodromal asthmatic phase, leads to an eosinophilic stage, which can evol
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::67a28d4287c0eeb3deaaad80c1d54e6d
https://doi.org/10.1093/ndt/gfaa142.p0373
Zobrazit plný text záznamu
9
AB0470 EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS (EGPA) - ONE-YEAR FOLLOW-UP STUDY USING MEPOLIZUMAB ANTI-IL5 THERAPY AS A STEROID SPARING THERAPEUTIC APPROACH
Autor: M. Martinez Del-Pero, Pasupathy Sivasothy, C. Owen, Lisa C. Willcocks, Stella Burns, Rona M Smith, D. R. W. Jayne, Allyson Egan, R. Gore
Publikováno v: Annals of the Rheumatic Diseases. 79:1533-1534
Background:EGPA is a small vessel vasculitis characterised by the presence of tissue eosinophilia, necrotising vasculitis and granulomatous inflammation1. Typically, a prodromal asthmatic phase, leads to an eosinophilic stage, which can evolve to inc
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::c1b7d61e4bd0cfe58af4a38d1b42fcc4
https://doi.org/10.1136/annrheumdis-2020-eular.6555
Zobrazit plný text záznamu
10
Rituximab for maintenance of remission in ANCA-associated vasculitis: expert consensus guidelines-Executive summary
Autor: Paul A. Brogan, David Jayne, Chetan Mukhtyar, Oliver Flossmann, David D'Cruz, Neil Basu, Joanna Tieu, Lucy Smyth, Alan D. Salama, Fiona A Pearce, Raashid Luqmani, Lorraine Harper, Rona M Smith, Richard A. Watts, Stephen P. McAdoo, Rachel B Jones, Lisa C. Willcocks, Joanna Robson, Peter Lanyon, Neeraj Dhaun, Charles D. Pusey
Publikováno v: Rheumatology (Oxford, England). 59(4)
© 2019 The Author(s) 2019. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. Anti-neutrophil cytoplasm antibody (ANCA)-associated vasculitis (AAV) encompasses three disease phenotypes: granu
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a905d3ab016655b38a41d27e57b60c04
https://pubmed.ncbi.nlm.nih.gov/32096542
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje